Balance Labs, Inc. (BLNC)
OTCMKTS · Delayed Price · Currency is USD
1.550
-0.020 (-1.27%)
At close: Nov 26, 2025
Balance Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.04 | 0.01 | - | - | 0.25 | 0.62 | |
Revenue Growth (YoY) | - | - | - | - | -60.37% | -37.54% |
Cost of Revenue | 13.32 | 12.89 | 0.19 | 0.06 | 0.05 | 0.15 |
Gross Profit | -13.28 | -12.89 | -0.19 | -0.06 | 0.2 | 0.48 |
Selling, General & Admin | 0.24 | 0.22 | 0.09 | 0.06 | 0.22 | 0.25 |
Operating Expenses | 0.24 | 0.22 | 0.09 | 0.06 | 0.22 | 0.25 |
Operating Income | -13.51 | -13.11 | -0.27 | -0.12 | -0.02 | 0.22 |
Interest Expense | -0.16 | -0.21 | -0.23 | -0.22 | -0.23 | -0.24 |
Interest & Investment Income | - | - | - | - | 0 | 0.05 |
Earnings From Equity Investments | - | - | - | - | -0.05 | -0.01 |
Other Non Operating Income (Expenses) | -1.94 | -1.94 | - | - | - | - |
EBT Excluding Unusual Items | -15.62 | -15.26 | -0.5 | -0.34 | -0.3 | 0.02 |
Gain (Loss) on Sale of Investments | -0.07 | -0.04 | -0.03 | -0.04 | -0.32 | -1.02 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.15 |
Other Unusual Items | -15.89 | -16.47 | - | - | -0.15 | 0.03 |
Pretax Income | -31.58 | -31.77 | -0.53 | -0.38 | -0.77 | -0.81 |
Earnings From Continuing Operations | -31.58 | -31.77 | -0.53 | -0.38 | -0.77 | -0.81 |
Minority Interest in Earnings | - | - | - | - | - | 0.01 |
Net Income | -31.58 | -31.77 | -0.53 | -0.38 | -0.77 | -0.8 |
Net Income to Common | -31.58 | -31.77 | -0.53 | -0.38 | -0.77 | -0.8 |
Shares Outstanding (Basic) | 32 | 26 | 22 | 22 | 22 | 22 |
Shares Outstanding (Diluted) | 32 | 26 | 22 | 22 | 22 | 22 |
Shares Change (YoY) | 47.73% | 18.69% | - | - | - | -13.02% |
EPS (Basic) | -0.99 | -1.23 | -0.02 | -0.02 | -0.04 | -0.04 |
EPS (Diluted) | -0.99 | -1.23 | -0.02 | -0.02 | -0.04 | -0.04 |
Free Cash Flow | -0.38 | -0.26 | -0.16 | -0.12 | 0.01 | -0.06 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | - | -0.00 |
Gross Margin | - | - | - | - | 79.86% | 76.71% |
Operating Margin | -34951.91% | -218426.78% | - | - | -9.23% | 35.93% |
Profit Margin | -81682.35% | -529472.08% | - | - | -310.44% | -127.55% |
Free Cash Flow Margin | -974.92% | -4283.73% | - | - | 3.13% | -9.11% |
EBITDA | - | - | - | - | -0.02 | 0.22 |
EBITDA Margin | - | - | - | - | -9.19% | 35.94% |
D&A For EBITDA | - | - | - | - | 0 | 0 |
EBIT | -13.51 | -13.11 | -0.27 | -0.12 | -0.02 | 0.22 |
EBIT Margin | - | - | - | - | -9.23% | 35.93% |